APO Research
Talk to an analyst

APO RESEARCH · REPORT

Image Guided Therapy

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Image Guided Therapy Market Outlook and Growth Opportunities 2026

31 December 2025196 pages

Choose your research edition.

Industry ResearchImage Guided Therapy Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Image Guided Therapy Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Image Guided Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Image Guided Therapy Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Image Guided Therapy Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Image Guided Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Image Guided Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Image Guided Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Image Guided Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Image Guided Therapy market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Image Guided Therapy market include Siemens Healthineers, Philips Healthcare, Olympus Corporation, Medtronic Plc, Lumicell, Lightpoint Medical, IGT, GE Healthcare and Fujifilm Holdings Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Image Guided Therapy market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Image Guided Therapy and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Image Guided Therapy revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Image Guided Therapy market.

Image Guided Therapy Segment by Company

Siemens Healthineers

Philips Healthcare

Olympus Corporation

Medtronic Plc

Lumicell

Lightpoint Medical

IGT

GE Healthcare

Fujifilm Holdings Corporation

Elekta

EchoPixel

Brainlab AG

Image Guided Therapy Segment by Type

Ultrasound

Magnetic Resonance Imaging

Interventional X-Ray

Others

Image Guided Therapy Segment by Application

Specialist Clinic

Hospital

Research and Academic Institutions

Outpatient Surgery Center

Image Guided Therapy Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Image Guided Therapy status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Image Guided Therapy key companies, revenue, market share, and recent developments.

3. To split the Image Guided Therapy breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Image Guided Therapy market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Image Guided Therapy significant trends, drivers, influence factors in global and regions.

6. To analyze Image Guided Therapy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Image Guided Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Image Guided Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Image Guided Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Image Guided Therapy industry.

Chapter 3: Detailed analysis of Image Guided Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Image Guided Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Image Guided Therapy in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Image Guided Therapy Industry Trends Table 2. Image Guided Therapy Industry Drivers Table 3. Image Guided Therapy Industry Opportunities and Challenges Table 4. Image Guided Therapy Industry Restraints Table 5. Global Image Guided Therapy Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Image Guided Therapy Revenue Share by Company (2021-2026) Table 7. Global Image Guided Therapy Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Image Guided Therapy Key Company Manufacturing Base & Headquarters Table 9. Global Image Guided Therapy Company, Product Type & Application Table 10. Global Image Guided Therapy Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Image Guided Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Ultrasound Table 15. Significant Companies of Magnetic Resonance Imaging Table 16. Significant Companies of Interventional X-Ray Table 17. Significant Companies of Others Table 18. Global Image Guided Therapy Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Image Guided Therapy Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Image Guided Therapy Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Image Guided Therapy Sales Value Share by Type (2021-2026) Table 22. Global Image Guided Therapy Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Specialist Clinic Table 24. Significant Companies of Hospital Table 25. Significant Companies of Research and Academic Institutions Table 26. Significant Companies of Outpatient Surgery Center Table 27. Global Image Guided Therapy Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Image Guided Therapy Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Image Guided Therapy Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Image Guided Therapy Sales Value Share by Application (2021-2026) Table 31. Global Image Guided Therapy Sales Value Share by Application (2027-2032) Table 32. Global Image Guided Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Image Guided Therapy Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Image Guided Therapy Sales Value Share by Region (2021-2026) Table 35. Global Image Guided Therapy Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Image Guided Therapy Sales Value Share by Region (2027-2032) Table 37. Global Image Guided Therapy Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Image Guided Therapy Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Image Guided Therapy Sales Value Market Share by Country (2021-2026) Table 40. Global Image Guided Therapy Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Image Guided Therapy Sales Value Market Share by Country (2027-2032) Table 42. Siemens Healthineers Company Information Table 43. Siemens Healthineers Business Overview Table 44. Siemens Healthineers Image Guided Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Siemens Healthineers Image Guided Therapy Product Portfolio Table 46. Siemens Healthineers Recent Development Table 47. Philips Healthcare Company Information Table 48. Philips Healthcare Business Overview Table 49. Philips Healthcare Image Guided Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Philips Healthcare Image Guided Therapy Product Portfolio Table 51. Philips Healthcare Recent Development Table 52. Olympus Corporation Company Information Table 53. Olympus Corporation Business Overview Table 54. Olympus Corporation Image Guided Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Olympus Corporation Image Guided Therapy Product Portfolio Table 56. Olympus Corporation Recent Development Table 57. Medtronic Plc Company Information Table 58. Medtronic Plc Business Overview Table 59. Medtronic Plc Image Guided Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Medtronic Plc Image Guided Therapy Product Portfolio Table 61. Medtronic Plc Recent Development Table 62. Lumicell Company Information Table 63. Lumicell Business Overview Table 64. Lumicell Image Guided Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Lumicell Image Guided Therapy Product Portfolio Table 66. Lumicell Recent Development Table 67. Lightpoint Medical Company Information Table 68. Lightpoint Medical Business Overview Table 69. Lightpoint Medical Image Guided Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Lightpoint Medical Image Guided Therapy Product Portfolio Table 71. Lightpoint Medical Recent Development Table 72. IGT Company Information Table 73. IGT Business Overview Table 74. IGT Image Guided Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. IGT Image Guided Therapy Product Portfolio Table 76. IGT Recent Development Table 77. GE Healthcare Company Information Table 78. GE Healthcare Business Overview Table 79. GE Healthcare Image Guided Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. GE Healthcare Image Guided Therapy Product Portfolio Table 81. GE Healthcare Recent Development Table 82. Fujifilm Holdings Corporation Company Information Table 83. Fujifilm Holdings Corporation Business Overview Table 84. Fujifilm Holdings Corporation Image Guided Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Fujifilm Holdings Corporation Image Guided Therapy Product Portfolio Table 86. Fujifilm Holdings Corporation Recent Development Table 87. Elekta Company Information Table 88. Elekta Business Overview Table 89. Elekta Image Guided Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Elekta Image Guided Therapy Product Portfolio Table 91. Elekta Recent Development Table 92. EchoPixel Company Information Table 93. EchoPixel Business Overview Table 94. EchoPixel Image Guided Therapy Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. EchoPixel Image Guided Therapy Product Portfolio Table 96. EchoPixel Recent Development Table 97. Brainlab AG Company Information Table 98. Brainlab AG Business Overview Table 99. Brainlab AG Image Guided Therapy Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Brainlab AG Image Guided Therapy Product Portfolio Table 101. Brainlab AG Recent Development Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Image Guided Therapy Product Image Figure 2. Global Image Guided Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Image Guided Therapy Market Size (2021-2032) & (US$ Million) Figure 4. Global Image Guided Therapy Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Ultrasound Image Figure 8. Magnetic Resonance Imaging Image Figure 9. Interventional X-Ray Image Figure 10. Others Image Figure 11. Global Image Guided Therapy Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Image Guided Therapy Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Image Guided Therapy Sales Value Share by Type (2021-2032) Figure 14. Specialist Clinic Image Figure 15. Hospital Image Figure 16. Research and Academic Institutions Image Figure 17. Outpatient Surgery Center Image Figure 18. Global Image Guided Therapy Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Image Guided Therapy Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Image Guided Therapy Sales Value Share by Application (2021-2032) Figure 21. Global Image Guided Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Image Guided Therapy Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Image Guided Therapy Sales Value (2021-2032) & (US$ Million) Figure 24. North America Image Guided Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Image Guided Therapy Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Image Guided Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Image Guided Therapy Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Image Guided Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Image Guided Therapy Sales Value (2021-2032) & (US$ Million) Figure 30. South America Image Guided Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Image Guided Therapy Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Image Guided Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Image Guided Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Image Guided Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Image Guided Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Ultrasound
  • Magnetic Resonance Imaging
  • Interventional X-Ray
  • Others
Applications
  • Specialist Clinic
  • Hospital
  • Research and Academic Institutions
  • Outpatient Surgery Center
Companies covered
  • Siemens Healthineers
  • Philips Healthcare
  • Olympus Corporation
  • Medtronic Plc
  • Lumicell
  • Lightpoint Medical
  • IGT
  • GE Healthcare
  • Fujifilm Holdings Corporation
  • Elekta
  • EchoPixel
  • Brainlab AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Image Guided Therapy Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Image Guided Therapy Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Image Guided Therapy Market Dynamics
  1. 2.1 Image Guided Therapy Industry Trends
  2. 2.2 Image Guided Therapy Industry Drivers
  3. 2.3 Image Guided Therapy Industry Opportunities and Challenges
  4. 2.4 Image Guided Therapy Industry Restraints
3 Image Guided Therapy Market by Company
  1. 3.1 Global Image Guided Therapy Company Revenue Ranking in 2025
  2. 3.2 Global Image Guided Therapy Revenue by Company (2021-2026)
  3. 3.3 Global Image Guided Therapy Company Ranking (2024-2026)
  4. 3.4 Global Image Guided Therapy Company Manufacturing Base and Headquarters
  5. 3.5 Global Image Guided Therapy Company Product Type and Application
  6. 3.6 Global Image Guided Therapy Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Image Guided Therapy Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Image Guided Therapy Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Image Guided Therapy Market by Type
  1. 4.1 Image Guided Therapy Type Introduction
  2. 4.1.1 Ultrasound
  3. 4.1.2 Magnetic Resonance Imaging
  4. 4.1.3 Interventional X-Ray
  5. 4.1.4 Others
  6. 4.2 Global Image Guided Therapy Sales Value by Type
  7. 4.2.1 Global Image Guided Therapy Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Image Guided Therapy Sales Value by Type (2021-2032)
  9. 4.2.3 Global Image Guided Therapy Sales Value Share by Type (2021-2032)
5 Image Guided Therapy Market by Application
  1. 5.1 Image Guided Therapy Application Introduction
  2. 5.1.1 Specialist Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Research and Academic Institutions
  5. 5.1.4 Outpatient Surgery Center
  6. 5.2 Global Image Guided Therapy Sales Value by Application
  7. 5.2.1 Global Image Guided Therapy Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Image Guided Therapy Sales Value by Application (2021-2032)
  9. 5.2.3 Global Image Guided Therapy Sales Value Share by Application (2021-2032)
6 Image Guided Therapy Regional Value Analysis
  1. 6.1 Global Image Guided Therapy Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Image Guided Therapy Sales Value by Region (2021-2032)
  3. 6.2.1 Global Image Guided Therapy Sales Value by Region: 2021-2026
  4. 6.2.2 Global Image Guided Therapy Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Image Guided Therapy Sales Value (2021-2032)
  7. 6.3.2 North America Image Guided Therapy Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Image Guided Therapy Sales Value (2021-2032)
  10. 6.4.2 Europe Image Guided Therapy Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Image Guided Therapy Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Image Guided Therapy Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Image Guided Therapy Sales Value (2021-2032)
  16. 6.6.2 South America Image Guided Therapy Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Image Guided Therapy Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Image Guided Therapy Sales Value Share by Country, 2025 VS 2032
7 Image Guided Therapy Country-level Value Analysis
  1. 7.1 Global Image Guided Therapy Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Image Guided Therapy Sales Value by Country (2021-2032)
  3. 7.2.1 Global Image Guided Therapy Sales Value by Country (2021-2026)
  4. 7.2.2 Global Image Guided Therapy Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Image Guided Therapy Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Image Guided Therapy Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Image Guided Therapy Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Image Guided Therapy Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Image Guided Therapy Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Image Guided Therapy Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Image Guided Therapy Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Image Guided Therapy Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Image Guided Therapy Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Image Guided Therapy Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Image Guided Therapy Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Image Guided Therapy Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Image Guided Therapy Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Image Guided Therapy Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Image Guided Therapy Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Image Guided Therapy Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Image Guided Therapy Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Image Guided Therapy Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Image Guided Therapy Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Image Guided Therapy Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Image Guided Therapy Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Image Guided Therapy Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Image Guided Therapy Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Image Guided Therapy Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Image Guided Therapy Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Image Guided Therapy Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Image Guided Therapy Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Image Guided Therapy Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Image Guided Therapy Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Image Guided Therapy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Siemens Healthineers
  2. 8.1.1 Siemens Healthineers Company Information
  3. 8.1.2 Siemens Healthineers Business Overview
  4. 8.1.3 Siemens Healthineers Image Guided Therapy Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Siemens Healthineers Image Guided Therapy Product Portfolio
  6. 8.1.5 Siemens Healthineers Recent Developments
  7. 8.2 Philips Healthcare
  8. 8.2.1 Philips Healthcare Company Information
  9. 8.2.2 Philips Healthcare Business Overview
  10. 8.2.3 Philips Healthcare Image Guided Therapy Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Philips Healthcare Image Guided Therapy Product Portfolio
  12. 8.2.5 Philips Healthcare Recent Developments
  13. 8.3 Olympus Corporation
  14. 8.3.1 Olympus Corporation Company Information
  15. 8.3.2 Olympus Corporation Business Overview
  16. 8.3.3 Olympus Corporation Image Guided Therapy Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Olympus Corporation Image Guided Therapy Product Portfolio
  18. 8.3.5 Olympus Corporation Recent Developments
  19. 8.4 Medtronic Plc
  20. 8.4.1 Medtronic Plc Company Information
  21. 8.4.2 Medtronic Plc Business Overview
  22. 8.4.3 Medtronic Plc Image Guided Therapy Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Medtronic Plc Image Guided Therapy Product Portfolio
  24. 8.4.5 Medtronic Plc Recent Developments
  25. 8.5 Lumicell
  26. 8.5.1 Lumicell Company Information
  27. 8.5.2 Lumicell Business Overview
  28. 8.5.3 Lumicell Image Guided Therapy Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lumicell Image Guided Therapy Product Portfolio
  30. 8.5.5 Lumicell Recent Developments
  31. 8.6 Lightpoint Medical
  32. 8.6.1 Lightpoint Medical Company Information
  33. 8.6.2 Lightpoint Medical Business Overview
  34. 8.6.3 Lightpoint Medical Image Guided Therapy Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lightpoint Medical Image Guided Therapy Product Portfolio
  36. 8.6.5 Lightpoint Medical Recent Developments
  37. 8.7 IGT
  38. 8.7.1 IGT Company Information
  39. 8.7.2 IGT Business Overview
  40. 8.7.3 IGT Image Guided Therapy Revenue and Gross Margin (2021-2026)
  41. 8.7.4 IGT Image Guided Therapy Product Portfolio
  42. 8.7.5 IGT Recent Developments
  43. 8.8 GE Healthcare
  44. 8.8.1 GE Healthcare Company Information
  45. 8.8.2 GE Healthcare Business Overview
  46. 8.8.3 GE Healthcare Image Guided Therapy Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GE Healthcare Image Guided Therapy Product Portfolio
  48. 8.8.5 GE Healthcare Recent Developments
  49. 8.9 Fujifilm Holdings Corporation
  50. 8.9.1 Fujifilm Holdings Corporation Company Information
  51. 8.9.2 Fujifilm Holdings Corporation Business Overview
  52. 8.9.3 Fujifilm Holdings Corporation Image Guided Therapy Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Fujifilm Holdings Corporation Image Guided Therapy Product Portfolio
  54. 8.9.5 Fujifilm Holdings Corporation Recent Developments
  55. 8.10 Elekta
  56. 8.10.1 Elekta Company Information
  57. 8.10.2 Elekta Business Overview
  58. 8.10.3 Elekta Image Guided Therapy Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Elekta Image Guided Therapy Product Portfolio
  60. 8.10.5 Elekta Recent Developments
  61. 8.11 EchoPixel
  62. 8.11.1 EchoPixel Company Information
  63. 8.11.2 EchoPixel Business Overview
  64. 8.11.3 EchoPixel Image Guided Therapy Revenue and Gross Margin (2021-2026)
  65. 8.11.4 EchoPixel Image Guided Therapy Product Portfolio
  66. 8.11.5 EchoPixel Recent Developments
  67. 8.12 Brainlab AG
  68. 8.12.1 Brainlab AG Company Information
  69. 8.12.2 Brainlab AG Business Overview
  70. 8.12.3 Brainlab AG Image Guided Therapy Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Brainlab AG Image Guided Therapy Product Portfolio
  72. 8.12.5 Brainlab AG Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst